# Single vs. Dual-DCCV in Obese Patients

Study · id `cardio:ct-nct04539158` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04539158](<https://clinicaltrials.gov/study/NCT04539158>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04539158

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04539158. Randomized; single masking; primary purpose treatment. Start 2020-08-07 (actual); primary completion 2023-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04539158, source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)
- Started: 2020-08-07 (actual) (ClinicalTrials.gov record NCT04539158, source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)
- Primary completion: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT04539158, source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)
- Completion: 2023-07-31 (anticipated) (ClinicalTrials.gov record NCT04539158, source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04539158, source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04539158-2023-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Single vs. Dual-DCCV in Obese Patients
- Condition: Atrial Fibrillation
- Intervention (Device): Direct Current Cardioversion
- Lead sponsor: Dr. Daniel P Morin, MD MPH FHRS
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial (`cardio:pubmed-38776097`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a3da518e25010ce9f0666f7917f01f9dbab5ebd7b24723f9a9e8ed54ac897bdb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
